BioSpace News Archive

AB Science SA (Euronext - FR0010557264 - AB) today announces that Health Canada has granted authorization to file a New Drug Submission for masitinib in the treatment of amyotrophic lateral sclerosis (ALS) under the Notice of Compliance with Conditions (NOC/c) policy.

The report offers detailed overview of the market with recent market dynamics and industrial status.

The industry analysis report is considered a valuable source of information about the global Microbiology Culture industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The report further provides details about each segments and regions covered in the global Surgical Needle market. The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

Irish medical device company, Neuromod Devices Ltd. (Neuromod), has welcomed the findings of an independent study performed at the German Hearing Center (DHZ) at Hannover Medical School, which found that 85% of tinnitus patients experienced a reduction in their tinnitus symptoms (based on the Tinnitus Handicap Inventory score[i] across 20 patients) when using the Lenire treatment device.

Increasing preference for self-injection devices, rising demand for biologics and increasing investments in research and development activities are some key factors expected to fuel market growth.

According to Emergen Research, the global hearing aids market size was USD 5,825.34 million in 2020 and is expected to reach USD 9,532.66 million in 2028 and register a revenue CAGR of 6.3% during the forecast period, 2021-2028.

Increasing awareness about advantages of stem cell therapy and rising demand for regenerative medicine worldwide are key factors expected to drive Stem Cell Therapy market revenue growth.

Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced plans to participate in the upcoming Citi Virtual Healthcare Conference.